Company Profile
Novartis
Novartis develops innovative medicines across oncology, cardiovascular, immunology, and neuroscience through global research and clinical programs.
What They Build
Innovative Medicines
Customer Type
Healthcare Systems, Patients
Business Model
Patented Drugs
Key Products & Initiatives
- Novartis operates global drug discovery and development pipelines across multiple therapeutic areas.
- Oncology, cardiovascular, immunology, and neuroscience remain central strategic franchises.
- Advanced therapy and biologics capabilities complement traditional small-molecule development.
- Clinical trial execution and regulatory strategy are core capabilities for global launches.
- Sandoz separation sharpened company focus on innovative medicines portfolio growth.
- Commercial execution depends on evidence generation, market access, and lifecycle management.
Key Products & Brands
Entresto
CardiovascularEntresto is a major Novartis cardiovascular therapy used in heart failure care pathways. Product impact is driven by clinical outcomes data, guideline inclusion, and physician adoption. Lifecycle strategy includes evidence expansion and global access considerations.
Cosentyx
ImmunologyCosentyx addresses immune-mediated conditions through biologic therapy pathways. Commercial and clinical teams support broad specialist adoption and long-term disease management use. Ongoing evidence and indication strategy influence market performance.
Kisqali
OncologyKisqali is a key Novartis oncology product in breast cancer care contexts. Product value depends on trial evidence, treatment sequencing data, and oncology guideline integration. Cross-functional teams coordinate clinical, regulatory, and access strategies globally.
Novartis R&D Pipeline
Drug Discovery and DevelopmentPipeline programs span early discovery through late-stage clinical development in multiple modalities. Teams manage scientific risk, trial execution, and regulatory pathway planning. Portfolio decisions are shaped by probability of technical and commercial success.
Role Families
R&D & Biomedical Engineering
Expected Skills
What They Work On
- Designing and executing discovery and translational research workflows for priority disease areas.
- Analyzing preclinical and clinical data to support indication and trial decisions.
- Supporting technical development of drug modalities with robust quality and reproducibility standards.
Portfolio Ideas
- Build a translational analysis project linking biomarker data to treatment response hypotheses.
- Create a reproducible pipeline for trial-subgroup outcome analysis.
- Prototype a portfolio prioritization model using clinical and technical risk inputs.
Clinical Operations & Quality
Expected Skills
What They Work On
- Coordinating trial operations, site readiness, and protocol adherence across geographies.
- Managing regulatory submission timelines and compliance documentation workflows.
- Analyzing safety, efficacy, and market-access data for launch and lifecycle decisions.
Portfolio Ideas
- Build a trial-operations dashboard with enrollment, site, and protocol deviation metrics.
- Create a regulatory milestone tracker with risk-based escalation logic.
- Design a post-launch evidence monitoring workflow for lifecycle management.
Entry Pathways
internships
Novartis internships include research, clinical, data science, and operations roles with exposure to real pipeline work. Interns often contribute to analysis or project deliverables reviewed by scientific and business teams. Selection emphasizes scientific rigor and communication.
entry Level Roles
Entry opportunities include clinical operations, data analysis, regulatory support, and select R&D tracks. Candidates with strong statistics and biomedical context are competitive. Demonstrating compliance and quality awareness is important.
graduate Programs
Early-career pathways include graduate-level science roles, fellowship-like tracks, and direct team hiring depending on function and region. Postdoctoral and advanced-degree routes are common for research-heavy positions. Intern and thesis alignment with therapeutic areas can strengthen candidacy.
Culture Signals
Novartis highlights science-driven innovation and patient-outcome impact as central themes.
The 'unbossed' concept is used to signal empowered ownership and collaboration.
Global trial execution and regulatory quality are emphasized in operating practices.
Portfolio focus on innovative medicines is reflected in strategic messaging post-Sandoz separation.
Cross-functional collaboration among research, clinical, and market-access teams is expected.